期刊文献+

应用寡核苷酸芯片鉴别肺鳞癌Ⅰb期特异相关基因 被引量:2

Identification of stageⅠb specific related genes in lung squmous cell cancer by oligonucleotide array
原文传递
导出
摘要 目的建立Ⅰb和Ⅲa期肺鳞癌的基因表达谱并筛选肺鳞癌Ⅰb期特异相关基因。方法收集肺正常、临床Ⅰb和Ⅲa期肺鳞癌组织,分别组成样品池,提取其总RNA并制备cDNA,合成生物素标记的cRNA探针,与人U133A寡核苷酸基因芯片进行杂交,以MSV5.0软件对其结果进行分析处理,在Affymetrix数据库进行信息查询,并以逆转录聚合酶链反应(RTPCR)验证芯片检测结果。结果按照多组平行比较的原则进行共筛选,以信号值对数比(signallogratio,SLR)均大于1为筛选标准,肺鳞癌差异表达基因:Ⅰb期共计1764个,其中上调571个,下调1193个;Ⅲa期共计554个,上调128个,下调426个。相对于Ⅲa期基因表达谱,Ⅰb期特异的差异表达基因共有1329个,其中上调482个,下调847个,对其进行生物学功能分类,其中代谢相关480个,信号转导227个,细胞增殖136个,免疫相关136个,细胞黏附94个,转录调控88个,细胞周期86个,细胞骨架73个,细胞分化45个,细胞凋亡42个,胞外基质31个。FOXM1和TNXB基因的RTPCR检测结果与基因芯片检测结果一致。结论在全基因组范围内建立了Ⅰb和Ⅲa期肺鳞癌的基因表达谱并筛选了肺鳞癌Ⅰb期特异相关基因,为进一步的癌变机制研究和鉴定肺鳞癌早期诊断分子标记物奠定了基础。 Objective To establish gene expression profile of stage Ⅰ b and Ⅲ a primary lung squmous cell cancer (SCC) within whole genome and identify genes specifically expressed in stage Ⅰb of SCC. Methods Total RNA was extracted from the normal, stage Ⅰ b and Ⅲ a lung SCC tissue, cRNA probes prepared from total RNA were hybridized with pretreatment oligonucleotide chip containing 22215 genes. The resultant data were treated with MSV 5.0 software and looked up on the affymetrix website. RTPCR examination were used to validated the results from chip analysis. Results Comparing with the normal lung, difference genes expressed in Ⅰ b SCC .are totally 1764, amomg which 571 were upregulated and 1193 were downregulated, and in stage Ⅲ a, they are 554, 128 and 426 genes respectively. Genes specifically expressed in stage Ⅰ b were totally 1329, including 482 upregulation genes and 847 downregulation genes, which were classified into different category which included 480 metabolism related genes, 227 signal transduction genes, 136 cell proliferation genes, 136 immune related genes, 94 cell adhere genes, 88 transcription regulation genes, 86 cell cycle genes, 73 cytoskeleton genes, 45 differentiation genes, 42 apoptosis and 31 extracellular matrix genes. RT-PCR examination of FOXM1 and TNXB genes was consistent with the analysis of gene chip. Conclusion Stage Ⅰ b and Ⅲ a Gene expression profile of primary SCC within the whole genome were set up and genes specificially expressed in stage Ⅰ b of SCC were identified, which lay a foundation for further research on carcinogenesis mechanism and identifying new markers of early diagnosis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第37期2623-2628,共6页 National Medical Journal of China
基金 广州市科技计划基金资助项目(No.2002JICO121)
关键词 寡核苷酸芯片 鉴别诊断 肺鳞癌Ⅰb期 特异相关基因 基因表达 Lung neoplasms Gene expression profile Oligonucleotide array
  • 相关文献

参考文献14

  • 1廖美琳.肺癌的以手术为主的多学科治疗[J].中华医学杂志,2003,83(3):181-182. 被引量:5
  • 2Li A, Zhang XS, Jiang JH, et al. Transeriptional carcinoma and its oncogenic potential. Cell Cycle, 2004,4:304-309.
  • 3The Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nature review, 2004,5:229-237.
  • 4Seifart C, Seifart U, Plagens A, et al. Surfactant protein B gene variations enhance ssceptibility to squamous cell carcinoma of the lung in German patients. Br J Cancer, 2002,15,87:212-217.
  • 5Skriagina EM, Abramovskaia AK, Gurevich CL, et al. Differential diagnosis significance of measuring surfactant phospholipid levels in lung diseases. Probl Tuberk, 1998, 4: 51-53.
  • 6Mao JR, Taylor G, Dean WB, et al. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet,2002, 30:421-425.
  • 7Lau D, Xue L, Hu R, et al. Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis. Am J Respir Cell Mol Biol, 2000, 22: 92-96.
  • 8Lau D, Guo L, Chan A, et al. SPR1. An early molecular marker for bronchial carcinogenesis. Methods Mol Med, 2003, 75:397-403.
  • 9Hu R, Wu R, Deng J, et al. A small proline-rich protein, spr1:specific marker for squamous lung carcinoma. Lung Cancer, 20:25-30.
  • 10Katoh M, Katoh M. Human FOX gene family expression of RPMS1 in nasopharyngeal. Int J Oncol,2004, 25: 1495-500.

共引文献4

同被引文献32

  • 1Kalinichenko VV, Major ML, Wang X, et al. Foxmlb transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the pl9ARF tumor suppressor. Genes Dev, 2004, 18: 830-850.
  • 2Madureira PA, Varshochi R, Constantinidou D, et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem, 2006, 281: 25167-25176.
  • 3Liu M, Dai B, Kang SH, et al. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res, 2006, 66 : 3593-3602.
  • 4Wang Z, Banerjee S, Kong D, et al. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res, 2007, 67: 8293-8300.
  • 5Kim IM, Ackerson T, Ramakrishna S, et al. The Forkhead Box M1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res, 2006, 66 : 2153-2161.
  • 6Radhakrishnan SK, Bhat UG, Hughes DE, et al. Identification of a chemical inhibitor of the oncogenic transcription factor Forkhead Box M1. Cancer Res, 2006, 66: 9731-9735.
  • 7Gusarova GA, Wang IC, Major ML, et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. Clin Invest, 2007, 117: 99-111.
  • 8Wang IC, Chen YJ, Hughes D, et al. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem, 2008, 283 : 20770-20778.
  • 9Dai B, Kang SH, Gong W, et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene, 2007, 26 : 6212-6219.
  • 10Zhang YJ, Zhang N, Dai BB, et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res, 2008, 68: 8733-8742.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部